Lepu Medical Technology (Beijing) Co., Ltd. (SHE:300003)
China flag China · Delayed Price · Currency is CNY
14.57
-0.27 (-1.82%)
Apr 24, 2026, 3:04 PM CST

SHE:300003 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Operating Revenue
6,2806,3446,0597,91610,55310,613
Other Revenue
138.99138.9944.264.2456.9346.74
6,4196,4836,1037,98010,60910,660
Revenue Growth (YoY)
8.47%6.22%-23.52%-24.79%-0.47%32.61%
Cost of Revenue
2,4552,4452,5562,9824,0214,166
Gross Profit
3,9634,0383,5474,9986,5886,494
Selling, General & Admin
1,8161,8782,2362,4402,7762,858
Research & Development
829.6792.38769.56879.42957.06907.94
Other Operating Expenses
97.769.4363.2858.3733.9103.14
Operating Expenses
2,7852,7793,1193,4043,7933,882
Operating Income
1,1781,259427.991,5942,7952,612
Interest Expense
-279.28-176.64-181-170.65-188.78-228.49
Interest & Investment Income
103.38120.96115.51115.3487.9957.59
Currency Exchange Gain (Loss)
-49.71-49.7126.91-25.3816.146.58
Other Non Operating Income (Expenses)
-37.01-31.3-34.13-4.22-25.77-79.03
EBT Excluding Unusual Items
915.551,122355.291,5092,6842,368
Impairment of Goodwill
---62.95-33.45--
Gain (Loss) on Sale of Investments
0.481.55-89.32-13.44-70.91-367.54
Gain (Loss) on Sale of Assets
5.174.8711.73-4.070.0219.9
Asset Writedown
-38.14-39.62-65.5-6.93-1.72-2.39
Other Unusual Items
126.9126.976.52103.55-127.71
Pretax Income
1,0101,216225.761,5542,6122,146
Income Tax Expense
144.98197.0728.47262.15365.73365.73
Earnings From Continuing Operations
864.981,019197.291,2922,2461,780
Minority Interest in Earnings
-34.7-5749.64-34.15-42.28-61.09
Net Income
830.28962.01246.941,2582,2041,719
Net Income to Common
830.28962.01246.941,2582,2041,719
Net Income Growth
478.16%289.57%-80.37%-42.91%28.18%-4.58%
Shares Outstanding (Basic)
1,8431,8431,8481,8621,8021,792
Shares Outstanding (Diluted)
1,8431,8431,8481,8621,8171,808
Shares Change (YoY)
-0.10%-0.27%-0.74%2.48%0.50%1.75%
EPS (Basic)
0.450.520.130.681.220.96
EPS (Diluted)
0.450.520.130.681.210.95
EPS Growth
478.71%290.64%-80.23%-44.29%27.54%-6.22%
Free Cash Flow
612.61873.8675.82145.691,8852,078
Free Cash Flow Per Share
0.330.470.040.081.041.15
Dividend Per Share
0.3260.3260.2770.3310.3410.275
Dividend Growth
17.51%17.51%-16.42%-2.81%24.00%20.61%
Gross Margin
61.75%62.28%58.12%62.63%62.10%60.92%
Operating Margin
18.36%19.42%7.01%19.97%26.34%24.50%
Profit Margin
12.94%14.84%4.05%15.77%20.77%16.13%
Free Cash Flow Margin
9.54%13.48%1.24%1.83%17.77%19.49%
EBITDA
-1,841927.052,0403,2053,004
EBITDA Margin
-28.40%15.19%25.57%30.21%28.18%
D&A For EBITDA
-581.89499.06446.75410.11392.37
EBIT
1,1781,259427.991,5942,7952,612
EBIT Margin
18.36%19.42%7.01%19.97%26.34%24.50%
Effective Tax Rate
14.36%16.21%12.61%16.86%14.00%17.04%
Revenue as Reported
6,4196,4836,1037,98010,60910,660
Advertising Expenses
-20.1928.4984.2360.0876.04
Source: S&P Global Market Intelligence. Standard template. Financial Sources.